Investors
Adjuvant Capital

Adjuvant Capital is a venture capital fund specializing in early to mid-stage companies in biotech, health tech, and manufacturing. They invest $10 million to $25 million in firms addressing significant health challenges. Notable investments include Memo Therapeutics, Univercells, and LimmaTech Biologics. Adjuvant Capital aims to make a global impact by supporting solutions for high-burden and neglected diseases.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Recent Investments